首页> 外文期刊>Systems biomedicine. >Methodological approach from the Best Overall Team in the sbv IMPROVER Diagnostic Signature Challenge
【24h】

Methodological approach from the Best Overall Team in the sbv IMPROVER Diagnostic Signature Challenge

机译:sbv IMPROVER诊断签名挑战赛最佳总体团队的方法论方法

获取原文
       

摘要

The sbv IMPROVER Diagnostic Signature Challenge used crowdsourcing to identify the best methods to classify clinical samples using transcriptomics data. Participating teams used public microarray data sets to develop prediction models in four disease areas, and then made predictions on blinded test data generated by the organizers. Here we describe the approach of the team for the Perinatology Research Branch (Team PRB; AL Tarca, R Romero), that was awarded the best performing entrant prize out of 54 entrants. The key elements of our approach included: (1) selection of training data sets by trial and error; (2) removal of batch effects by pre-processing the test and training data together; (3) the use of statistical significance and magnitude of change to select biomarkers; and (4) optimization of the number of biomarkers via the cross-validated performance of a simple linear discriminant analysis (LDA) model. Not only were our resulting models ranked consistently high, but they also generated parsimonious signatures of as low as two genes, unlike most of the other top-ranked teams that used hundreds of genes for prediction.
机译:sbv IMPROVER Diagnostic Signature Challenge使用众包来确定使用转录组学数据对临床样本进行分类的最佳方法。参加团队使用公共微阵列数据集来开发四个疾病领域的预测模型,然后对组织者生成的盲法测试数据进行预测。在这里,我们介绍了Perinatology研究部(PRB团队; AL Tarca,R Romero)团队的方法,该团队在54名参赛者中获得了表现最好的参赛者奖。我们方法的关键要素包括:(1)通过反复试验选择训练数据集; (2)通过对测试和培训数据进行预处理来消除批次效应; (3)利用统计显着性和变化幅度选择生物标志物; (4)通过简单的线性判别分析(LDA)模型的交叉验证性能来优化生物标志物的数量。与大多数其他使用数百个基因进行预测的排名最高的团队不同,我们产生的模型不仅始终保持较高的排名,而且还生成了低至两个基因的简约特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号